Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00262262
Status:
COMPLETED
Last Update Posted:
2007-11-26
First Post:
2005-12-05
Brief Title:
The Effect of Levetiracetam on the Postmastectomy Pain Syndrome
Sponsor:
Odense University Hospital
Organization:
Odense University Hospital
Study Overview
Official Title:
The Effect of Levetiracetam on the Postmastectomy Pain Syndrome
Status:
COMPLETED
Status Verified Date:
2007-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is determine whether or not the antiepileptic drug Levetiracetam is an effective treatment of the postmastectomy pain syndrome
Detailed Description:
This study is a randomised placebocontrolled doubleblind study on the effect of the antiepileptic drug levetiracetam in patients suffering from PMPS The treatment periods are 1 month each and the periods are separated by a 1-week washout period The daily dose of levetiracetam is increased over a 2-week period to 3000 mgday The primary effect variable is pain relief by the use of numeric rating scale Secondary parameters are daily registration of pain performed by the patients during the treatment periods and the amount of escape medicine used paracetamol and tramadol Sensory testing is performed at baseline and after each treatment period
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| PubliRC CNS 085 TA 1007 LEV | None | None | None |